Group 1 - Core viewpoint: Yinos BioTech Co., Ltd. has seen a stock price increase of 5.15%, reaching 45.13 CNY per share, with a total market capitalization of 6.362 billion CNY as of October 27 [1] - Company overview: Yinos BioTech, established on May 12, 2010, is located in the China (Shanghai) Pilot Free Trade Zone and specializes in providing non-clinical research services in the biopharmaceutical sector, with 96.31% of its revenue coming from non-clinical services [1] - Revenue breakdown: The company's revenue composition includes 96.31% from non-clinical services, 3.42% from clinical services, and 0.27% from other sources [1] Group 2 - Major shareholder: Jiashi Fund's Jiashi Medical Health Stock A (005303) has entered the top ten circulating shareholders of Yinos, holding 344,300 shares, which is 1.22% of the circulating shares [2] - Fund performance: Jiashi Medical Health Stock A has achieved a year-to-date return of 41.06%, ranking 1050 out of 4219 in its category, and a one-year return of 34.73%, ranking 1293 out of 3877 [2] - Fund manager details: The fund manager, Sun Xiaohui, has a tenure of 200 days with a best return of 36.44%, while the other manager, Hao Miao, has a tenure of 6 years and 286 days with a best return of 183.83% [3]

Group 1 - The core viewpoint of the news is that Yinosh Biotechnology Co., Ltd. has seen a stock price increase of 5.11%, reaching 50.80 CNY per share, with a total market capitalization of 7.162 billion CNY as of September 25 [1] - Yinosh specializes in providing non-clinical research services in the biopharmaceutical sector, with 96.31% of its revenue coming from non-clinical services, 3.42% from clinical services, and 0.27% from other sources [1] - The company is located in the China (Shanghai) Pilot Free Trade Zone and was established on May 12, 2010, with its listing date set for September 3, 2024 [1] Group 2 - Among Yinosh's top ten circulating shareholders, a fund under Harvest Fund Management, specifically the Harvest Medical Health Stock A (005303), has entered the top ten, holding 344,300 shares, which is 1.22% of the circulating shares [2] - The Harvest Medical Health Stock A fund has achieved a year-to-date return of 46.46%, ranking 892 out of 4220 in its category, and a one-year return of 60.55%, ranking 1402 out of 3820 [2] - The fund was established on December 4, 2017, and has a current size of 786 million CNY, with an overall return since inception of 99.56% [2] Group 3 - The fund manager of Harvest Medical Health Stock A is Sun Xiaohui, who has been in the position for 168 days, achieving a best return of 39.35% during his tenure [3] - The other fund manager, Hao Miao, has been managing the fund for 6 years and 254 days, with a best return of 183.83% and a worst return of -29.32% during his tenure [3]

Core Insights - Yinos Bio's stock price increased by 5.01% on September 17, reaching 45.28 CNY per share, with a trading volume of 1.21 billion CNY and a turnover rate of 3.06%, resulting in a total market capitalization of 6.384 billion CNY. The stock has risen for five consecutive days, with a cumulative increase of 14.8% during this period [1] Company Overview - Shanghai Yinos Biotechnology Co., Ltd. is located in the China (Shanghai) Pilot Free Trade Zone and was established on May 12, 2010. The company went public on September 3, 2024. Its main business involves providing comprehensive research and development services (CRO) focused on non-clinical research services in biomedicine [1] - The revenue composition of Yinos Bio is as follows: non-clinical services account for 96.31%, clinical services for 3.42%, and other services for 0.27% [1] Shareholder Information - Among Yinos Bio's top ten circulating shareholders, one fund from Harvest Fund Management, the Harvest Medical Health Stock A (005303), entered the top ten in the second quarter, holding 344,300 shares, which represents 1.22% of the circulating shares. The estimated floating profit today is approximately 743,700 CNY, with a total floating profit of 1.9145 million CNY during the five-day increase [2] - The Harvest Medical Health Stock A fund was established on December 4, 2017, with a current scale of 786 million CNY. Year-to-date returns are 46.61%, ranking 574 out of 4222 in its category; the one-year return is 62.24%, ranking 1519 out of 3804; and since inception, the return is 99.77% [2] Fund Manager Performance - The fund manager of Harvest Medical Health Stock A is Sun Xiaohui, who has been in the position for 160 days, managing assets totaling 985 million CNY, with the best fund return during this period being 41.81% and the worst being 41.31% [3] - Co-manager Hao Miao has been in the role for 6 years and 246 days, managing assets of 3.652 billion CNY, with the best fund return during this period being 183.83% and the worst being -27.96% [3]

Company Overview - Yinos Biotech Co., Ltd. is located in the China (Shanghai) Pilot Free Trade Zone and was established on May 12, 2010. The company is set to be listed on September 3, 2024. Its main business involves providing comprehensive research and development services (CRO) focused on non-clinical research services in the biopharmaceutical sector [1] - The revenue composition of Yinos is as follows: non-clinical services account for 95.42%, clinical services for 4.11%, and other services for 0.47% [1] Stock Performance - On September 1, Yinos shares increased by 5.1%, reaching a price of 40.98 CNY per share, with a trading volume of 30.95 million CNY and a turnover rate of 2.75%. The total market capitalization is 5.777 billion CNY [1] Shareholder Information - Among the top ten circulating shareholders of Yinos, one fund from Harvest Fund Management, the Harvest Medical Health Stock A (005303), entered the top ten in the second quarter, holding 344,300 shares, which represents 1.22% of the circulating shares. The estimated floating profit for today is approximately 685,200 CNY [2] - The Harvest Medical Health Stock A fund was established on December 4, 2017, with a current size of 786 million CNY. Year-to-date returns are 42.3%, ranking 534 out of 4222 in its category. Over the past year, returns are 50.75%, ranking 1765 out of 3779, and since inception, the fund has achieved a return of 93.9% [2] Fund Management - The fund manager for Harvest Medical Health Stock A is Sun Xiaohui, who has been in position for 144 days, with a total fund size of 985 million CNY. The best return during his tenure is 37.64%, while the worst is 37.22% [3] - The other fund manager, Hao Miao, has been in position for 6 years and 230 days, managing a total fund size of 3.652 billion CNY. His best return during his tenure is 183.83%, while the worst is -30.4% [3]